18 September 2018

New Hires Advance AMRA into the Asian Market and Expand European Growth

New Hires Advance AMRA into the Asian Market and Expand European Growth

Sweden, September 18, 2018: AMRA, the international leader in body composition analysis, announced today three new significant hires, each bringing a wealth of knowledge and experience to support the company’s continued growth and global expansion.

As AMRA’s first formal advancement into the Asian market, Thomas Jonsson joins as the Director of Business Development for Japan. With more than 25 years’ experience in the East Asian life science industry, Mr. Jonsson will be based in Japan, thus providing a close proximity and relationship to customers and partners. Jonsson brings to the team a strong background in commercial sales and leadership from across leading industry players including AstraZeneca, Pfizer, and Merck, as well as years of experience working with biotechs focused on imaging and software.

“I strongly believe that the highly science-focused pharmaceutical and academic organizations in Japan will find AMRA digital health products very useful for their research and clinical development” stated Thomas.

AMRA has also recruited Vittorio Sportelli, PharmD RPh, as the new Regional Director of Business Development for Europe and the Middle East. Dr. Sportelli is a registered pharmacist in Italy and Switzerland, as well as a trained specialist in clinical nutrition and dietetics, with a passion for metabolic disturbances and nutritional assessment in chronic and acute disease. Vittorio brings more than 15 years of experience in the healthcare business, as well as in several new market segments within the hospital and pharmaceutical industries.

“I feel honored to join such strong and talented team of professionals at AMRA Medical and I am glad to embrace AMRA’s mission of establishing the foundation for body composition measurement and providing the knowledge needed to predict and prevent disease,” expressed Vittorio.

The third, key individual to join the Swedish headquarter as the new Business Development Manager MSK is Magnus Aurell, who holds more than 25 years of experience in business development and international sales across the medical technology, imaging, and pharmaceutical landscape. Prior to AMRA, he was the CEO of the public Swedish imaging company, EXINI Diagnostics AB, which was profitably sold to a renowned American company.

“We are proud to welcome Thomas, Vittorio, and Magnus to the team. AMRA’s continued progress into new markets and territories led by these key individuals will ensure new and strong international opportunities, thus reinforcing the company’s mission to keep confronting global health challenges,” said CEO Tommy Johansson.

In addition, AMRA welcomes Marie Olsson, who joins as Analysis Engineer working in Quality Assurance, Andrea Robina as Marketing Manager, and Per Widholm, who joins the Clinical Science Team as Lead Scientist, MSK.

AMRA is a ground-breaking international digital health company at the forefront of medical imaging and precision medicine. The company has developed a new global standard in body composition assessment, the ability to automatically produce multiple fat and muscle biomarkers with unrivaled precision and accuracy, as well as contextual disease insights – all from a single, 6-minute, whole-body MRI. AMRA was founded in 2010 as a spin-off of Linköping University, Sweden, with the aim to support transformative care and vital decision-making from clinical research to health and wellness.


Marie Börjesson
Senior Director, Brand & Marketing


Latest News


Meet Us Here